PolyNovo Hits Record $A10M Revenue in April
Company Announcements

PolyNovo Hits Record $A10M Revenue in April

Polynovo Limited (AU:PNV) has released an update.

PolyNovo Limited has achieved a milestone with a record-breaking revenue of $A10.1 million in April 2024, demonstrating significant growth with U.S. sales up by approximately 75% from the same time last year and Rest of World sales increasing by roughly 68%. The company’s expansion into new markets and the application of their products in various plastic and reconstructive surgeries have contributed to their global impact, now reaching over 42,000 patients across 39 countries.

For further insights into AU:PNV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskPolyNovo Limited Expands Global Reach and Sales
TipRanks Australian Auto-Generated NewsdeskPolynovo Limited Announces New Share Quotation
TipRanks Australian Auto-Generated NewsdeskPolyNovo Director Steps Down, Retains Share Interest
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App